Rarus Technologies Inc. (RARS): rumored as the new pick of Eric Van’s websites. We traded RARS stock from $.45 to $.55 and will keep it on watch for the future developments.
Just before market close the Rarus Technologies released 8-K Form:
[note color=”#D3D5DB”]On May 8, 2012 (the “Effective Date”), Rarus Technologies Inc., a Nevada corporation (the “Company”), entered into a software property, technical information and trademark license agreement (the “License Agreement”) with ThinkCorp AG, (the “Licensor”) a copy of which is attached hereto as Exhibit 10.1.
Under the License Agreement, the Company has acquired software properties and software property applications is an Internet technology business concept called “Zngle”. Zngle is a social media platform that allows members to make posts to specific zones including: family, friends, acquaintances, colleague, custom, dating, and community. It allows members to communicate with traditional SMS chat along with video mail, voice chat and video messaging, it also has a mobile app that utilizes the API system for zngle.com with an enhanced geo location feature coupled with augmented reality to create a interactive experience with local businesses.
The License Agreement provides the Company with the rights to technical information including all unpublished research and development information, the formulation of proprietary products, method, software inventions, know-how, trade secrets, and technical data that are needed to support the Zngle business concept, including a worldwide exclusive license to the “Zngle” trademark and all of its likenesses and to certain software, source code, technical information, trademarks, and domain names which were developed and/or owned by ThinkCorp AG including, but not limited to: zngle.net, zngle.com and zngle.ca (the “License”). The term of the License, to the extent of the Licensed Territory, is 500 years beginning from the Effective Date. In exchange for the License, the Company has agreed to make the following scheduled payments to ThinkCorp AG:
- Two Million US Dollars by May 8, 2013;
- Three Million US Dollars by May 8, 2014;
- Five Million US Dollars by May 8, 2015;
- Five Million US Dollars by May 8, 2016;
- Seven Million US Dollars by May 8, 2017
The total scheduled payments to be made by the Company to ThinkCorp AG due during the entire 60 month period is Twenty Two Million US Dollars ($22,000,000). Additionally, the Company has also agreed to pay ThinkCorp AG a five percent (5%) royalty on all net sales derived from the use of the software properties, technical information and trademarks within the agreed territory.[/note]
Is this a new AwesomePennyStocks (and other Eric Van’s websites) pick? Rarus is “An Exploration Stage Company” (according to the its quarterly report) with zero cash, zero revenue and current market cap is about $250M. Perfect scam to be promoted. eom
Znlge is dedicated to building mobile and online solutions that create seamless relationships between social media and local businesses. Its proprietary research and trade data helps merchants define their target markets and understand key consumer buying trends. Zngle extends the life of a business’s marketing program by creating lasting consumer relationships that drive growth and build the bottom line.
Well, so far the Eric’s newsletters still talk about Sunpeaks Ventures (SNPK):
[note color=”#D3D5DB”]Hi Everyone,
We rarely revisit picks but we think that SNPK is at absolute bargain levels right now and it could bounce very high as the company has big things lined up on the agenda.
The company still has its $9 target price (which is 4,000% from current levels) and strong buy recommendation issued by the research firm. The company also still has Paul Silas, Burt Reynolds, The Portland Trail Blazers, and The Dayton Dragons on its side.
SNPK also has plans to: get Clotamin into almost 500 Walgreens locations + in up to 11,200 stores thanks to the AACSA + in pharmacies across Russia and in over 100 other retailer/pharmacies around the nation!
Clotamin is also now available nationwide online on Amazon, Walgreens, and Ebay!
SNPK is still associated with Acosta (the company that works with Walmart, and Target) Both of these huge names could be very beneficial in moving Clotamin off the shelves!
Those of you who did want to buy SNPK but thought it was trading too high can buy SNPK for just a little under 20 cents!
It looks like SNPK has bottomed and there could be huge upside from this point on starting tomorrow!
Your AwesomePennyStocks Editor.[/note]
Sunpeaks Ventures, Inc.
9337 Fraser Ave.
Silver Spring, MD 20910
Tel: (204) 898-8160
Sunpeaks Ventures, Inc (“Sunpeaks”), and wholly owned subsidiary Healthcare Distribution Specialists, LLC (“HDS”), is a nationally focused, value-added distributor of specialty drugs and over-the-counter (“OTC”) branded multivitamins to the healthcare provider market. HDS is currently analyzing several OTC products that would allow us to become a powerful over-the-counter player in the multi-billon dollar health supplement market.